LC-Plasma on Immune Response and Reducing Symptoms of Upper Respiratory Infectious Diseases

Clinical trial NCT06837961 · COMPLETED

Trial details

NCT number: NCT06837961
Sponsor: RDC Clinical Pty Ltd
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Healthy Volunteer Immune Response

Start date: 2025-04-29
Primary completion: 2025-11-03
Enrollment: 241

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.